Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 14/20 | 0.82 |
| ▸ | MEN1 | O00255 | 2/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.82 |
| ▸ | USP2 | O75604 | 1/20 | 0.82 |
| ▸ | LMNA | P02545 | 1/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trandolaprilat SCHEMBL156829 | 1.00 | ACE (0.82) | ACEMEN1KMT2AUSP2LMNA | |
| Trandolaprilat SCHEMBL11076552 | 1.00 | ACE (0.82) | ACEMEN1KMT2AUSP2LMNA | |
| Trandolaprilat SCHEMBL678354 | 1.00 | ACE (0.82) | ACEMEN1KMT2AUSP2LMNA | |
| Trandolaprilat SCHEMBL9173132 | 1.00 | ACE (0.82) | ACEMEN1KMT2AUSP2LMNA | |
| Trandolaprilat SCHEMBL683838 | 1.00 | ACE (0.82) | ACEMEN1KMT2AUSP2LMNA | |
| Trandolaprilat SCHEMBL9173121 | 1.00 | ACE (0.82) | ACEMEN1KMT2AUSP2LMNA | |
| Trandolaprilat SCHEMBL11286342 | 1.00 | ACE (0.82) | ACEMEN1KMT2AUSP2LMNA | |
| Trandolaprilat SCHEMBL5794079 | 1.00 | ACE (0.82) | ACEMEN1KMT2AUSP2LMNA | |
| Trandolaprilat SCHEMBL9173113 | 1.00 | ACE (0.82) | ACEMEN1KMT2AUSP2LMNA | |
| Trandolaprilat SCHEMBL7388097 | 1.00 | ACE (0.82) | ACEMEN1KMT2AUSP2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070225505-A1 | Method for the Preparation of (2S, 3AR, 7AS)-Octahydro-III-Indole-2-Carboxylic Acid as Key Intermediate in the Preparation of Trandolapril by Reacting a Cyclohexyl Aziridine with a Dialkyl Malonate | TEXCONTOR ETABLISSEMENT (LI) | 2007-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225505-A1 | Method for the Preparation of (2S, 3AR, 7AS)-Octahydro-III-Indole-2-Carboxylic Acid as Key Intermediate in the Preparation of Trandolapril by Reacting a Cyclohexyl Aziridine with a Dialkyl Malonate | IDO1, TPH1, AGTR1 | ACE 151/4885MEN1 1294/4885KMT2A 1702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.